Article
[Usefulness of p53 in the clinical management of bladder tumors].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 1 Apr 2001
Bernardini S, Chabannes E, Bittard H
Abstract excerpt
The antioncogene p53 has been the subject of many studies in the field of bladder cancer, for many years and there appears to be a good correlation between p53 protein overexpression and pejorative clinicopathological factors, but contradictory results have been reported concerning its prognostic value. These discordances can be partly explained by the various immunohistochemical methods used in published series....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.